Response
Collaborative transition to a methadone formulation change in British Columbia, Canada

https://doi.org/10.1016/j.drugpo.2016.04.002Get rights and content

Section snippets

Acknowledgements

The authors would like to thank S. Solven, Deputy Registrar of the College of Pharmacists of British Columbia and Dr. A. McNestry of the College of Physicians and Surgeons of British Columbia for their input and support.

References (3)

There are more references available in the full text version of this article.

Cited by (2)

  • “It's about bloody time”: Perceptions of people who use drugs regarding drug law reform

    2019, International Journal of Drug Policy
    Citation Excerpt :

    Research has pointed out the impacts of not including the affected community in drug policy reform. For instance, in 2014 several regulatory reforms in British Columbia, Canada resulted in changes to methadone maintenance treatment to a ten-times more concentrated methadone formulation (‘Methadose’) and restrictions in pharmacy delivery services (Greer, Amlani, & Buxton, 2016; McNeil et al., 2015). While some methadone patient groups were involved in developing community posters about the change, policy reforms and materials given to methadone patients were uninformed by patients themselves (Greer, Amlani et al., 2016, 2016).

View full text